ANEUVO

ANEUVO is a platform and therapy development company focused on treating disabling diseases and conditions that have not been curable through traditional pharmaceutical approaches.

The ANEUVO ExaStim® Stimulation System is a non-invasive neuromodulation system which has received CE Mark approval and FDA Breakthrough Device Designation for treating spinal cord injury.

ExaStim® is only cleared for use in Europe and is not commercially available in other geographies. ExaStim® is limited by United States law to investigational use.